Preclinical evidence showed the potent efficacy of remdesivir (a broad-spectrum antiviral nucleotide prodrug) to treat MERS-CoV and SARS-CoV infections. As 2019-nCoV is an emerging virus, an effective treatment has not been developed for disease resulting from this virus. Since the combination of lopinavir and ritonavir was already available in the designated hospital, a randomised controlled trial has been initiated quickly to assess the efficacy and safety of combined use of lopinavir and ritonavir in patients hospitalised with 2019-nCoV infection.柳叶刀文章
看了下价格, 100 mg $3950
https://www.medchemexpress.com/Remdesivir.html?src=google-product&gclid=Cj0KCQiAmsrxBRDaARIsANyiD1q_NnX7z-DolyjV8bTnWYOqGBmxy3HmjGybL7D4JRpAxcvHJEhSPZEaAleAEALw_wcB
这次的病人有用过这的吗？